Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    10831479 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Effectiveness of Aripiprazole for Improving Side Effects of Clozapine in the Treatment of People With Schizophrenia
Conditions: Schizophrenia;   Insulin Resistance
Interventions: Drug: Aripiprazole;   Drug: Placebo
2 Completed
Has Results
Ziprasidone for Clozapine- or Olanzapine-Associated Diabetes Mellitus
Condition: Schizophrenia
Intervention: Drug: Ziprasidone
3 Not yet recruiting 1/2-MC4R Genotype and Pediatric Antipsychotic Drug- Induced Weight Gain
Conditions: High Risk MC4R Genotype;   Low Risk MC4R Genotype;   One Week or Less Antipsychotic Lifetime Exposure
Interventions: Drug: Ziprasidone;   Drug: aripiprazole, quetiapine, or risperidone
4 Completed
Has Results
Rosiglitazone for Clozapine Induced Glucose Metabolism Impairment
Condition: Schizophrenia
Interventions: Drug: rosiglitazone;   Drug: placebo

Indicates status has not been verified in more than two years